Facebook
X
LinkedIn
ForwardCPD 1: LAN MAT: What You Need to Know - An Overview of Long-acting Naltrexone (LAN)
Opioid misuse and addiction is a serious national crisis.
- Affects public health and social and economic welfare.
- Daily, more than 90 Americans die after overdosing on opioids.
Treatment of opioid dependence is a national priority.
Increasing the knowledge of and accessibility to effective medication-assisted treatments (MATs) for opioid dependence is of utmost importance to address this serious, growing problem.
Health care providers need to be educated and equipped to provide MATs such as long-acting naltrexone in the primary care setting where there is great need for substance use disorder management.
Target Audience
Healthcare professionals in a primary care setting.
Learning Objectives
Upon completion of this educational activity, you will be able to:
1. Identify the evidence supporting use of injectable long-acting naltrexone (LAN) for treatment of opioid use disorder.
2. Describe injectable LAN’s use and place in therapy for the treatment of opioid use disorder.
3. Summarize pertinent patient and provider education for injectable LAN when used for treatment of opioid use disorder.
4. Classify LAN’s role in primary care.
Melanie Dicks, PharmD
Clinical Assistant Professor, Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-24-009-H08-P
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).
- 1.00 ASWB
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course.
Social workers completing this course receive 1.00 clinical continuing education credit(s).
- 1.00 ASWB - Clinical
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.